Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Business Times.
Press releases published on March 8, 2025

Atkore Inc. (ATKR) Investors: April 23, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
RADNOR, Pa., March 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer …

HTXMining Unveils Profitable Staking Opportunities for Easy Earnings in the Cryptocurrency Era
SHERIDAN, Wyoming , March 08, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency world rapidly evolves, liquidity mining has become the next frontier for earning passive income — without the need for expensive hardware or deep technical knowledge. HTXMining is …

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VOXX, CMRX, WBA, ML on Behalf of Shareholders
NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: …

ROSEN, A LEADING LAW FIRM, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELF
NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 …

Grabar Law Office is Investigating Potential Price-Fixing Claims on Behalf of Businesses that Purchase Eggs Directly from Major Egg Producers
PHILADELPHIA, March 08, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating potential price-fixing and anticompetitive practices in the U.S. egg industry on behalf of businesses that directly purchase eggs from major egg producers. This …

Curia kündigt strategische Refinanzierung zur Unterstützung weiteren Wachstums an
ALBANY, N.Y., March 08, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass es seine vorrangig gesicherten Kreditmittel refinanziert hat. Die Transaktion …

Curia anuncia refinanciación estratégica para apoyar su crecimiento continuo
ALBANY, Nueva York, March 08, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder en investigación, desarrollo y fabricación por contrato, anunció hoy la refinanciación de sus líneas de crédito senior garantizadas. La transacción …

Curia annonce un refinancement stratégique visant à soutenir la poursuite de sa croissance
ALBANY, New York, 08 mars 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), l’une des principales organisations de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui le refinancement de ses facilités de crédit garanties de …

Curia הכריזה על אסטרטגיית מימון מחדש לתמיכה בהמשך הצמיחה
אולבני, ניו יורק, March 08, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (קוריה), חברה מובילה למחקר, פיתוח וייצור לפי חוזים, הודיעה כי מימנה מחדש את מסגרות האשראי המובטחות הראשיות שלה. עסקה זו מספקת ל-Curia הון מצטבר ומאריכה את מועדי מסגרות האשראי המובטחות …

Curia Umumkan Pembiayaan Ulang (Refinancing) Strategis untuk Mendukung Pertumbuhan yang Berkelanjutan
ALBANY, N.Y., March 09, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak, hari ini mengumumkan telah melakukan pembiayaan ulang (refinancing) pada fasilitas kredit terjamin …

キュリア (Curia)、継続的な成長を支える戦略的リファイナンスを発表
ニューヨーク州オールバニ発 , March 09, 2025 (GLOBE NEWSWIRE) -- 研究開発・製造業務受託機関のリーダーであるキュリア・グローバル (Curia Global, Inc.) (キュリア) は本日、シニア・セキュアード・クレジット・ファシリティ (Senior Secured Credit Facilities) のリファイナンスを完了したことを発表した。 …

Curia, 지속적 성장 지원하기 위한 전략적 리파이낸싱 발표
올버니, 뉴욕, March 09, 2025 (GLOBE NEWSWIRE) -- 의약품 위탁 연구 및 개발, 제조(CDMO) 분야 선도 기업인 큐리아(Curia)가 선순위 담보 신용 시설을 리파이낸싱했다고 오늘 발표했다. 이번 거래를 통해 Curia는 추가 자본을 확보하고 담보 신용 시설의 만기를 연장함으로써 지속적인 성장 기반을 마련하게 되었다. 아울러 의약품 개발 및 제조 시장의 매력적인 시장 기회를 활용하는 한편 바이오 제약 고객과 협력해 삶을 …

Curia Mengumumkan Pembiayaan Semula Strategik untuk Menyokong Pertumbuhan Berterusan
ALBANY, N.Y., March 09, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), sebuah organisasi penyelidikan, pembangunan dan pembuatan kontrak yang terkemuka, hari ini mengumumkan pembiayaian semula kemudahan kredit terjamin senior organisasi itu. Urus …

Curia Anuncia Refinanciamento Estratégico em Apoio ao Crescimento Contínuo
ALBANY, N.Y., March 08, 2025 (GLOBE NEWSWIRE) -- A Curia Global, Inc. (Curia), uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje que refinanciou suas linhas de crédito seniores garantidas. A transação fornece à …

Curia ประกาศกลยุทธ์รีไฟแนนซ์เพื่อสนับสนุนการเติบโตอย่างต่อเนื่อง
ออลบานี นิวยอร์ก , March 09, 2025 (GLOBE NEWSWIRE) -- วันนี้ Curia Global, Inc. (Curia) ซึ่งเป็นองค์กรชั้นนำด้านการวิจัย การพัฒนา และการผลิตตามสัญญา ประกาศในวันนี้ว่าได้รีไฟแนนซ์วงเงินสินเชื่อที่มีหลักทรัพย์ค้ำประกันเพียงพอ การทำธุรกรรมครั้งนี้ช่วยให้ …

Curia 宣布战略性再融资,助力持续增长
奥尔巴尼,纽约州, March 09, 2025 (GLOBE NEWSWIRE) -- 业内领先的合同研发及制造企业 Curia Global, Inc. (Curia) 今日宣布,公司已完成其高级担保信贷设施的再融资工作。 这笔交易为 Curia 带来了额外资本,并延长了其担保信贷设施的到期时间,为公司持续增长奠定了基础,使其能够抓住药物研发和制造市场中的有利机遇,并推动其与生物制药客户合作、将改变生命的疗法推向市场的使命。 公司首席执行官 Philip Macnabb …

Curia 公佈策略性再融資,為持續增長提供支持
奧爾巴尼,紐約州, March 09, 2025 (GLOBE NEWSWIRE) -- 頂尖的合約研究、開發及製造企業 Curia Global, Inc. (Curia) 今天公佈已對其優先擔保的授信額度進行再次融資。 該項交易為 Curia 提供新增資本,延長了其授信額度的期限,為業務的持續增長做好準備,讓公司能夠善用藥物開發及製造市場中令人注目的市場機遇,以及推進公司與生物製藥客戶攜手合作,將改變生活的療法引入市場的使命。 行政總裁 Philip Macnabb …

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”), of the …

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch …

Communiqué de presse : Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD
Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD Cinq fois plus d’adultes traités par Dupixent présentaient une rémission soutenue à la semaine 36, comparativement à ceux …